2006-006212-30: A Randomised, Open labelled, Phase II, Immunogenicity, and Exploratory Efficacy Evaluation of Therapeutic Immunisations +/- IL-2, GM-CSF and Growth Hormone in HIV-1 Infected Subjects Receiving Highly Active Anti-retroviral Therapy (HAART). |
|
|
| Ongoing | 2 | 30 | Europe | Saizen, IR103, Proleukin, Leukine, IR103 is a combination of Remune and Amplivax, Saizen, Proleukin, Leukine, Saizen, Proleukin, Leukine | Imperial College London | HIV-1 | | | | |
